top-left-banner

Saturday, Oct 25th

Last update08:46:04 AM GMT

TwitterLinkedinYoutubeGoogleFeed

Banner

User1

User2c

User3

You are here: BioMedTech

BioMedTech

Cambridge firm is sleekness in Seattle

Cambridge HealthcareCambridge Healthcare, the UK startup whose technology is helping to revolutionise patient care, has opened a Seattle office to piggy-back reform in the United States.

Vernalis lands $1.5m Genentech milestone

Pharma technology business Vernalis plc, with research operations in Cambridge, has received a $1.5 million milestone payment under a drug discovery collaboration with Roche Group company, Genentech.

Vernalis CEO Ian GarlandGenentech was a trailblazer for the infant UK biotechnology sector when it was founded more than 30 years ago. It is headquartered in San Francisco.

Antibodies boost in translational medicine race

Chairman and CEO, Andy SandhamCambridge antibody technology powerhouse, Kymab, has founded a global academic think tank to accelerate research into translational medicines.

Biotech entrepreneur receives lifetime achievement award

From left to right – Steve Bates, BIA CEO, Andy Richards, BIA Lifetime Achievement Award winner, and Tim Edwards, BIA chairman.Cambridge life sciences entrepreneur Dr Andy Richards received the BioIndustry Association Lifetime Achievement Award at the Association’s annual gala dinner.

One Nucleus takes lead in challenging environment

Harriet Fear, CEO of One NucleusIt continues to be a challenging environment for the sector and One Nucleus remains mindful of the need to work very hard to ensure that all our activities provide a tangible benefit for members. With this in mind the company has two brand new initiatives, writes One Nucleus CEO, Harriet Fear.

Accelrys acquisition could stack up to $10 million

Accelrys President and CEO Max Carnecchia. Image courtesy of AccelrysNasdaq-quoted Accelrys, Inc, which has a major presence in Cambridge, has paid around $5 million cash for a long-term Swiss partner. The deal could eventually stack up to $10m based on future performance increments.

Telehealth to reach 1.8 million patients by 2017

Theo Ahadome, senior analyst at InMedicaIn 2012 there was estimated to be 308,000 patients remotely monitored by their healthcare provider for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, hypertension and mental health conditions worldwide. The majority of these were post-acute patients who have been hospitalised and discharged.

DNA store in a teacup

ick Goldman. Image courtesy – EMBL PhotolabResearchers at the EMBL-European Bioinformatics Institute (EMBL-EBI) in Cambridge UK have created a way to store data in the form of DNA – a material that lasts for tens of thousands of years.

Page 52 of 130